Sodium in PDB 9fs3: Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate

Enzymatic activity of Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate

All present enzymatic activity of Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate:
2.1.3.2; 3.5.1.2; 3.5.2.3; 6.3.4.16; 6.3.5.5;

Protein crystallography data

The structure of Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate, PDB code: 9fs3 was solved by F.Del Cano-Ochoa, S.Ramon-Maiques, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.75 / 1.18
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 82.099, 158.499, 61.842, 90, 90, 90
R / Rfree (%) 15.5 / 17.9

Other elements in 9fs3:

The structure of Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate also contains other interesting chemical elements:

Zinc (Zn) 4 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate (pdb code 9fs3). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate, PDB code: 9fs3:

Sodium binding site 1 out of 1 in 9fs3

Go back to Sodium Binding Sites List in 9fs3
Sodium binding site 1 out of 1 in the Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Mutant S1538L of the Dihydroorotase Domain of Human Cad Protein Bound to Carbamoyl Aspartate within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na1915

b:25.8
occ:1.00
 O A:HOH2268 2.2 23.8 1.0
O A:GLY1806 2.4 13.3 1.0
O A:HOH2328 2.4 21.0 1.0
O A:GLY1804 2.4 14.7 1.0
O A:GLU1524 2.5 16.0 1.0
O A:HOH2275 2.7 25.4 1.0
HA A:GLU1524 3.2 16.9 1.0
O A:HOH2007 3.3 22.7 1.0
C A:GLY1804 3.4 13.4 1.0
HA2 A:GLY1804 3.4 16.8 1.0
C A:GLU1524 3.5 14.4 1.0
HB3 A:GLU1524 3.5 17.4 1.0
C A:GLY1806 3.5 12.9 1.0
CA A:GLU1524 3.7 14.0 1.0
HA A:GLN1807 3.7 14.5 1.0
HG2 A:GLN1807 3.8 16.1 1.0
CA A:GLY1804 3.9 14.0 1.0
CB A:GLU1524 4.1 14.5 1.0
HG2 A:GLU1524 4.1 18.7 1.0
O A:HOH2337 4.2 37.4 1.0
N A:GLY1806 4.2 12.8 1.0
C A:TYR1805 4.2 13.2 1.0
HA3 A:GLY1804 4.2 16.8 1.0
H A:GLY1806 4.4 15.4 1.0
O A:TYR1805 4.4 14.3 1.0
N A:TYR1805 4.4 13.1 1.0
HG3 A:GLN1807 4.4 16.1 1.0
N A:GLN1807 4.5 12.7 1.0
CA A:GLY1806 4.5 12.6 1.0
CA A:GLN1807 4.5 12.1 1.0
CG A:GLN1807 4.5 13.4 1.0
O A:HOH2323 4.6 31.5 1.0
HA A:TYR1805 4.7 15.6 1.0
CG A:GLU1524 4.7 15.6 1.0
HE2 A:PHE1531 4.7 13.5 1.0
CA A:TYR1805 4.7 13.0 1.0
N A:ALA1525 4.7 13.7 1.0
O A:HOH2321 4.8 33.3 1.0
HA A:ALA1525 4.8 17.1 1.0
O A:HOH2058 4.9 16.2 1.0
HB2 A:GLU1524 4.9 17.4 1.0

Reference:

F.Del Cano-Ochoa, L.Ramadane-Morchadi, L.Eixeres, M.Moreno-Morcillo, R.Fernandez-Leiro, S.Ramon-Maiques. Disruption of Cad Oligomerization By Pathogenic Variants. J.Mol.Biol. V. 436 68832 2024.
ISSN: ESSN 1089-8638
PubMed: 39447673
DOI: 10.1016/J.JMB.2024.168832
Page generated: Tue Dec 10 21:21:01 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy